Enjoy the bags lads. Once again, I'm not interested in daily movements, rather long term growth.
We've got a very appealing pipeline ahead after the launch of Sofdra, however I believe that we will be bought out before that comes if the launch is successful. Management have always indicated that they want to sell.
Formalities aside, does anyone possess data indicating the average market penetration of newly approved FDA drugs within their first year?
BOT - Anything but charting, page-8923
-
- There are more pages in this discussion • 2,306 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $627.0M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.5¢ | 34.5¢ | $1.070M | 3.066M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 194068 | 34.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 116666 | 8 |
View Market Depth
| Last trade - 16.10pm 21/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |